Home/Filings/4/0001093557-20-000037
4//SEC Filing

MOY JEFFREY 4

Accession 0001093557-20-000037

CIK 0001093557other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 6:23 PM ET

Size

20.1 KB

Accession

0001093557-20-000037

Insider Transaction Report

Form 4
Period: 2020-02-18
MOY JEFFREY
V. P., Operations
Transactions
  • Other

    Common Stock

    2019-09-11+4,46131,819 total(indirect: By Trust)
  • Sale

    Common Stock

    2020-02-18$287.41/sh400$114,96528,315 total(indirect: By Trust)
  • Sale

    Common Stock

    2020-02-18$290.98/sh100$29,09825,220 total(indirect: By Trust)
  • Other

    Common Stock

    2019-09-114,46130,408 total
  • Sale

    Common Stock

    2020-02-18$283.37/sh610$172,85531,209 total(indirect: By Trust)
  • Sale

    Common Stock

    2020-02-18$284.23/sh1,694$481,48029,515 total(indirect: By Trust)
  • Sale

    Common Stock

    2020-02-18$286.55/sh800$229,23628,715 total(indirect: By Trust)
  • Sale

    Common Stock

    2020-02-18$288.99/sh2,795$807,71725,520 total(indirect: By Trust)
  • Sale

    Common Stock

    2020-02-18$289.84/sh200$57,96825,320 total(indirect: By Trust)
Footnotes (9)
  • [F1]Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.
  • [F2]Included in this number are 30,408 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 15,047 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,647 of which were granted on March 8, 2017 and shall vest through March 8, 2020.
  • [F3]Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.
  • [F4]On November 20, 2019, Mr. Moy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Moy. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  • [F5]This transaction was executed in multiple trades at prices ranging from $282.99 to $283.81. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $283.99 to $284.44. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F7]This transaction was executed in multiple trades at prices ranging from $286.03 to $287.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F8]This transaction was executed in multiple trades at prices ranging from $287.39 to $287.42. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F9]This transaction was executed in multiple trades at prices ranging from $288.71 to $289.70. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001446422

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 6:23 PM ET
Size
20.1 KB